A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
St. Jude Children's Research Hospital
Ruijin Hospital
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital